19.03.2020 - Japan’s AGC (formerly Asahi Glass Chemical) has launched a voluntary tender offer to buy Italian clinical-stage biotech Molecular Medicine, known as Molmed. Molmed focuses on...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)